Showing 20,681 - 20,700 results of 39,386 for search '(( significant decrease decrease ) OR ( significant ((level disease) OR (teer decrease)) ))', query time: 0.57s Refine Results
  1. 20681

    Data Sheet 1_Assessing cross-national inequalities and predictive trends in gout burden: a global perspective (1990–2021).pdf by Mingyang Li (516280)

    Published 2025
    “…Advanced analysis indicated substantial gaps between observed gout burden and optimal levels in high-SDI countries, such as the United States and Australia, highlighting unrealized opportunities for improving outcomes. …”
  2. 20682
  3. 20683
  4. 20684

    Table 6_Global burden of low back pain attributable to smoking in 204 countries and territories in 1990–2021.xlsx by Baodong Wang (3359171)

    Published 2025
    “…It uses data from the 2021 Global Burden of Disease (GBD), providing scientific evidence for policy-making.…”
  5. 20685

    Table 4_Global burden of low back pain attributable to smoking in 204 countries and territories in 1990–2021.xlsx by Baodong Wang (3359171)

    Published 2025
    “…It uses data from the 2021 Global Burden of Disease (GBD), providing scientific evidence for policy-making.…”
  6. 20686

    Table 5_Global burden of low back pain attributable to smoking in 204 countries and territories in 1990–2021.xlsx by Baodong Wang (3359171)

    Published 2025
    “…It uses data from the 2021 Global Burden of Disease (GBD), providing scientific evidence for policy-making.…”
  7. 20687

    Table 3_Global burden of low back pain attributable to smoking in 204 countries and territories in 1990–2021.xlsx by Baodong Wang (3359171)

    Published 2025
    “…It uses data from the 2021 Global Burden of Disease (GBD), providing scientific evidence for policy-making.…”
  8. 20688

    Table 7_Global burden of low back pain attributable to smoking in 204 countries and territories in 1990–2021.xlsx by Baodong Wang (3359171)

    Published 2025
    “…It uses data from the 2021 Global Burden of Disease (GBD), providing scientific evidence for policy-making.…”
  9. 20689

    Table 2_Global burden of low back pain attributable to smoking in 204 countries and territories in 1990–2021.xls by Baodong Wang (3359171)

    Published 2025
    “…It uses data from the 2021 Global Burden of Disease (GBD), providing scientific evidence for policy-making.…”
  10. 20690

    Image 1_Global burden of low back pain attributable to smoking in 204 countries and territories in 1990–2021.tif by Baodong Wang (3359171)

    Published 2025
    “…It uses data from the 2021 Global Burden of Disease (GBD), providing scientific evidence for policy-making.…”
  11. 20691

    Table 1_Global burden of low back pain attributable to smoking in 204 countries and territories in 1990–2021.xlsx by Baodong Wang (3359171)

    Published 2025
    “…It uses data from the 2021 Global Burden of Disease (GBD), providing scientific evidence for policy-making.…”
  12. 20692
  13. 20693

    Data Sheet 1_Elevated Galectin-3 levels in the tumor microenvironment of ovarian cancer – implication of ROS mediated suppression of NK cell antitumor response via tumor-associated... by Veronika Karlsson (20457788)

    Published 2024
    “…Introduction<p>Ovarian cancer is a lethal disease with low survival rates for women diagnosed in advanced stages. …”
  14. 20694
  15. 20695
  16. 20696

    DataSheet1_Exploring lipodystrophy gene expression in adipocytes: unveiling insights into the pathogenesis of insulin resistance, type 2 diabetes, and clustering diseases (metaboli... by Aditya Saxena (668441)

    Published 2024
    “…Background<p>Studying the molecular mechanisms of lipodystrophy can provide valuable insights into the pathophysiology of insulin resistance (IR), type 2 diabetes (T2D), and other clustering diseases [metabolic syndrome (MetS)] and its underlying adipocentric disease (MetS disease).…”
  17. 20697

    IgE Guided Use of ICS in Patients with Stable COPD: A Real-World Observational Study by Ziwei Zhou (2014384)

    Published 2025
    “…</p> <p>The total serum IgE level is closely related to exacerbations of COPD. …”
  18. 20698

    Table 3_The CATALYTIC tool to assess feasibility of implementing evidence-based interventions for cardiovascular diseases in 46 low- and middle-income countries: survey outcomes an... by Temitope Ojo (6391868)

    Published 2025
    “…Background<p>Evidence-based interventions (EBI) for cardiovascular disease (CVD) in low- and middle-income countries (LMIC) may face feasibility challenges due to the inadequacy of existing instruments. …”
  19. 20699

    Table 5_The CATALYTIC tool to assess feasibility of implementing evidence-based interventions for cardiovascular diseases in 46 low- and middle-income countries: survey outcomes an... by Temitope Ojo (6391868)

    Published 2025
    “…Background<p>Evidence-based interventions (EBI) for cardiovascular disease (CVD) in low- and middle-income countries (LMIC) may face feasibility challenges due to the inadequacy of existing instruments. …”
  20. 20700

    Table 1_The CATALYTIC tool to assess feasibility of implementing evidence-based interventions for cardiovascular diseases in 46 low- and middle-income countries: survey outcomes an... by Temitope Ojo (6391868)

    Published 2025
    “…Background<p>Evidence-based interventions (EBI) for cardiovascular disease (CVD) in low- and middle-income countries (LMIC) may face feasibility challenges due to the inadequacy of existing instruments. …”